A serious, three-month certification covering CTD and eCTD submissions, GMP, pharmacovigilance, and country-by-country drug registration across the GCC. For pharmacists building industry careers and working RA professionals leveling up.
Community and hospital pharmacists who want to break into the pharmaceutical industry through regulatory affairs — one of the highest-demand and best-paid career paths.
RA officers and specialists wanting structured upskilling on eCTD, GCC harmonisation, and the latest regulatory developments across SFDA, MOHAP, EDA, and SCH.
Companies onboarding new RA hires or building internal capability across GCC markets. We run private corporate cohorts customised to your portfolio.
Recent pharmacy and life sciences graduates looking to enter industry with a real, marketable specialisation that opens doors at multinationals and regional players.
The curriculum is structured around the actual work of a regulatory affairs professional — from first dossier preparation through lifecycle management, audit response, and pharmacovigilance. Every module includes case studies from real GCC submissions and a hands-on assessment.
The role of regulatory affairs in pharma, the global regulatory landscape, ICH guidelines, and how the GCC fits into international harmonisation efforts.
SFDA (Saudi Arabia), MOHAP & EDE (UAE), SCH (Kuwait), MOPH (Qatar), NHRA (Bahrain), MOH (Oman) — structures, jurisdictions, and how decisions actually get made.
The centralised drug registration pathway, how it interacts with national approvals, when to use it, when to file nationally, and how to think strategically about pathway selection.
Module 1–5 architecture, content requirements, GCC-specific Module 1 expectations, and the differences between EMA-style CTDs and what GCC reviewers want.
The transition to eCTD across GCC markets, technical requirements, validation tools, lifecycle management, and the publishing software landscape.
Module 3 in depth — drug substance, drug product, manufacturing process, specifications, stability data, and the most common quality deficiencies in GCC submissions.
Modules 4 and 5 — non-clinical study reports, clinical study reports, summary documents, and the bridging studies sometimes needed for GCC approval.
Bioequivalence requirements, biosimilar pathways, comparability studies, and the GCC's specific stance on each — including current SFDA priorities.
Variations (Type IA, IB, II), renewals, line extensions, and how to plan a multi-year regulatory strategy that doesn't lose authorisations through neglect.
GMP framework, GCC inspection programmes, mock audits, and how to prepare a manufacturing site for an SFDA or MOHAP inspection without panic.
The PV system, qualified person responsibilities (QPPV), adverse event reporting, signal detection, and how to build a PV system from scratch.
Country-specific PV obligations, periodic safety update reports (PSURs), the new SFDA requirements, and the GCC PV harmonisation roadmap.
The MDMA/MDEL system, device classification, technical documentation, and the differences between drug and device pathways across GCC authorities.
The notification systems for cosmetics, the supplement and nutraceutical regulatory landscape, and the herbal product registration pathway.
Label content requirements, mandatory languages, promotional material approval, and the evolving rules on digital and HCP-targeted promotion.
How drug pricing is determined across GCC markets, the SFDA pricing committee, reimbursement pathways, and the regulatory–commercial intersection.
How AI is changing dossier preparation, regulatory intelligence, and submission management — and what that means for your career trajectory.
A simulated end-to-end submission across two GCC markets, instructor review, peer feedback, and a final assessment leading to your certification.
Regulatory affairs is one of the few careers where you can learn the work and become valuable in months — not years. The GCC pharma industry is hiring.
— Lead instructor
Most international RA courses are excellent on the science and weak on regional reality. Most regional courses are short, surface-level, and don't take you far enough. KhaleejPro's program goes deep on both — international standards plus GCC-specific application.
Every module includes anonymised real submissions, deficiency letters, and approval correspondence from GCC authorities. You learn what reviewers actually flag.
Our instructors run RA functions at multinational pharma companies and consult to authorities. They teach because they want to — not as their main job.
Top-performing graduates are introduced to RA hiring managers across our employer network. We don't promise jobs — but we open doors.
Alumni receive The KhaleejPro Pharma Brief — a fortnightly digest of every new GCC regulatory development, summarised and made actionable.
If your question isn't here, talk to an advisor — fifteen minutes, no commitment. We'll give you a straight answer about whether this program is the right fit for you.
Reserve your seat in the next cohort, or book a 15-minute call with an advisor to figure out whether this is the right path for you.
Reserve your seat